Showing results (121-130 of 1,028) with videos related to

Sort By:
Pageof 103
The Lancet. Respiratory Medicine|October 13, 2022
Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trialNicola K Love, Derren R Ready, Charlie Turner, et al.
The Lancet. Respiratory Medicine|October 13, 2022
Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trialJohn W Eikelboom, Sanjit S Jolly, Emilie P Belley-Cote, et al.
The Lancet. Respiratory Medicine|December 2, 2023
Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort studyGee-Chen Chang, Chao-Hua Chiu, Chong-Jen Yu, et al.
The Lancet. Respiratory Medicine|November 24, 2023
3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort studyHui Zhang, Chaolin Huang, Xiaoying Gu, et al.
The Lancet. Respiratory Medicine|December 24, 2023
Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicineSara Cajander, Matthijs Kox, Brendon P Scicluna, et al.
The Lancet. Respiratory Medicine|December 18, 2023
Association of novel adult cough subclasses with clinical characteristics and lung function across six decades of life in a prospective, community-based cohort in Australia: an analysis of the Tasmanian Longitudinal Health Study (TAHS)Jingwen Zhang, Caroline J Lodge, E Haydn Walters, et al.
The Lancet. Respiratory Medicine|December 15, 2023
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trialMengzhao Wang, Yun Fan, Meili Sun, et al.
The Lancet. Respiratory Medicine|March 28, 2024
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled studyHossein-Ardeschir Ghofrani, Gérald Simonneau, Andrea M D'Armini, et al.
The Lancet. Respiratory Medicine|March 25, 2024
Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exerciseAnna K Coussens, Syed M A Zaidi, Brian W Allwood, et al.
The Lancet. Respiratory Medicine|February 26, 2024
Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapiesManu Shankar-Hari, Thierry Calandra, Miguel P Soares, et al.
Pageof 103